Home
Search
Study Topics
Glossary
|
|
|
|
|
Sponsored by: |
Sanofi-Aventis |
---|---|
Information provided by: | Sanofi-Aventis |
ClinicalTrials.gov Identifier: | NCT00535171 |
To determine the effect of an interventional campaign run by a dedicated "VTE Nurse Educator" over a 6-month period and the effect on prophylaxis rates. To determine the proportion of medically admitted patients with risk factors for VTE.
To assess and compare the use of venous thromboembolism (VTE) prophylaxis in hospitalized medical patients versus recommendations and current guidelines. To determine the patient characteristics of those deemed to be at risk of VTE. To determine the proportion of patients receiving appropriate thromboprophylaxis for their risk.
To determine the type and duration (where possible) of prophylaxis used.
Condition |
---|
Venous Thrombosis |
Study Type: | Observational |
Study Design: | Case-Only, Prospective |
Official Title: | Venous Thromboembolism Taskforce Audit Program |
Ages Eligible for Study: | 18 Years and older |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | No |
Sampling Method: | Probability Sample |
Venous thromboembolism in medical patients bedridden due to acute illness.
Inclusion Criteria:
Exclusion Criteria:
The above information is not intended to contain all considerations relevant to a patient's potential participation in a clinical trial.
Responsible Party: | sanofi-aventis ( Medical Affairs Study Director ) |
Study ID Numbers: | DIREG_L_01927 |
Study First Received: | September 25, 2007 |
Last Updated: | September 9, 2008 |
ClinicalTrials.gov Identifier: | NCT00535171 History of Changes |
Health Authority: | Australia: Department of Health and Ageing Therapeutic Goods Administration |
Embolism and Thrombosis Embolism Vascular Diseases Venous Thrombosis |
Venous Thromboembolism Thromboembolism Thrombosis |
Embolism and Thrombosis Vascular Diseases Cardiovascular Diseases Venous Thrombosis |
Venous Thromboembolism Thrombosis Thromboembolism |